FDLI Names New President and Chief Executive Officer

Posted on May 2014 by Michael Levin‐Epstein

FDLI Names New President and Chief Executive Officer Amy Comstock Rick to lead organization effective August 25th The Food and Drug Law Institute (FDLI) announces the selection of Amy Comstock Ric...read more

The Food and Drug Law Institute, the premier educational organization in the field of food and drug law, announced today that President and Chief Executive Officer Susan C. Winckler will step down ...read more

“Ravioli Trees and Tortellini Bushes: What Should Courts Expect from the Reasonable Consumer When it Comes to ‘Natural’ Claims?” is the timely topic addressed by John E. Vil...read more

The Harmonization of Cosmetics Standards Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on December 2013 by Michael Levin-Epstein, Editor-in-Chief, FDLI

“Is It Time for Harmonized Cosmetics Standards? A Comparison of U.S. and E.U. Cosmetics Regulation” is the topic addressed by Kimberly K. Egan, Founder, Saltbox Consulting and Jennifer ...read more

The Food and Drug Law Institute To Honor Axelrad, Gibbs, Holcombe, Kingham

Posted on December 2013 by Michel Levin-Epstein, Editor-in-Chief, FDLI

Honorees Will Receive Distinguished Service and Leadership Awards at Holiday Reception December 10 December 5, Washington, DC -- The Food and Drug Law Institute will honor four outstanding food and...read more

Constitutionality of State Biosimilar Substitution Bills Is Focus of New FDLI Food and Drug Law Policy Forum

Posted on September 2013 by Michael Levin-Epstein, Editor-in-Chief, FDLI

“Do Pending State Biosimilar Substitution Bills Violate State Constitutional Law Principles of Non-Delegation and Incorporation by Reference?” is the timely topic addressed by Neal Park...read more

read more

read more

read more